Cargando…
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Circulating tumor DNA (ctDNA) represents a promising biomarker for noninvasive assessment of cancer burden, but existing methods have insufficient sensitivity or patient coverage for broad clinical applicability. Here we introduce CAncer Personalized Profiling by deep Sequencing (CAPP-Seq), an econo...
Autores principales: | Newman, Aaron M., Bratman, Scott V., To, Jacqueline, Wynne, Jacob F., Eclov, Neville C. W., Modlin, Leslie A., Liu, Chih Long, Neal, Joel W., Wakelee, Heather A., Merritt, Robert E., Shrager, Joseph B., Loo, Billy W., Alizadeh, Ash A., Diehn, Maximilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134/ https://www.ncbi.nlm.nih.gov/pubmed/24705333 http://dx.doi.org/10.1038/nm.3519 |
Ejemplares similares
-
Integrated digital error suppression for improved detection of circulating tumor DNA
por: Newman, Aaron M., et al.
Publicado: (2016) -
Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013) -
Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
por: Binkley, Michael S., et al.
Publicado: (2016) -
Data normalization considerations for digital tumor dissection
por: Newman, Aaron M., et al.
Publicado: (2017) -
Cell-type specific gene expression profiles of leukocytes in human peripheral blood
por: Palmer, Chana, et al.
Publicado: (2006)